AbstractBackgroundBetween 25% and 40% of hospital admissions in elderly patients may be linked to drug-related problems. Therefore prevention and recognition of inappropriate prescribing of medicines in elderly patients is one of the principle health care quality and safety issues.AimTo identify and compare the rate of inappropriate prescribing in elderly patients using two validated screening tools: STOPP/START criteria and Beers criteria.Materials and methodsA cross-sectional observational study on prescriptions of 600 patients aged ≥65 years was conducted. STOPP/START criteria and Beers criteria were applied to detect inappropriate prescriptions. Feedback was obtained from clinicians about measures to reduce potentially inappropriate pre...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
BACKGROUND: Older persons are at significant risk of drug-related admissions (DRAs). We previously d...
One of the causes of preventable adverse drug events (EAM) in the older adult population is the inap...
AimTo date, there is no study comparing the Beers 2012 and Screening Tool of Older Person's Prescrip...
Background: Prescribing in elderly is a challenging task as they have age related physiological chan...
BackgroundInappropriate prescribing in the elderly is a critical issue in primary care, causing a hi...
BACKGROUND:Over the last few years, the Screening Tool of Older Person's Prescriptions (STOPP) and S...
ObjectivesTo provide baseline information on inappropriate prescribing (IP), and to evaluate whether...
Introduction Medication-related problems can cause serious adverse drug events (ADEs) that may lead ...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Balanced and safe prescribing is difficult to achieve in frail older adults with multiple comorbid d...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
BACKGROUND: Older persons are at significant risk of drug-related admissions (DRAs). We previously d...
One of the causes of preventable adverse drug events (EAM) in the older adult population is the inap...
AimTo date, there is no study comparing the Beers 2012 and Screening Tool of Older Person's Prescrip...
Background: Prescribing in elderly is a challenging task as they have age related physiological chan...
BackgroundInappropriate prescribing in the elderly is a critical issue in primary care, causing a hi...
BACKGROUND:Over the last few years, the Screening Tool of Older Person's Prescriptions (STOPP) and S...
ObjectivesTo provide baseline information on inappropriate prescribing (IP), and to evaluate whether...
Introduction Medication-related problems can cause serious adverse drug events (ADEs) that may lead ...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Balanced and safe prescribing is difficult to achieve in frail older adults with multiple comorbid d...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was p...
BACKGROUND: Older persons are at significant risk of drug-related admissions (DRAs). We previously d...